iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement

NEXT STORY
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform
PREV STORY
Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BiomX To Host Key Opinion Leader Event on BX003 for the Treatment of Inflammatory Bowel Disease

author_avatar
NASDAQ Market News

Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional ...

author_avatar
NASDAQ Market News

Amunix CEO to deliver keynote address on ProTIA, Amunix’s novel immuno-oncology technology, at the Biologics & Biosimilars Congress Europe (March 2018)

MOUNTAIN VIEW, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a ...

author_avatar
NASDAQ Market News